Tower Research Capital (TRC)’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$420 Sell
100
-138
-58% -$769 ﹤0.01% 5577
2026
Q2
$1.94K Buy
238
+180
+310% +$3.83K ﹤0.01% 4743
2026
Q1
$3.02K Buy
58
+56
+2,800% +$4.06K ﹤0.01% 4377
2025
Q4
$201 Buy
+2
New +$471 ﹤0.01% 4994

Other funds holding PMI

Tower Research Capital (TRC)'s PMI Position: Q3 2026 in Review

Tower Research Capital (TRC) reduced its Picard Medical (PMI) stake by 58% in Q3 2026, selling an estimated $769 and leaving 100 shares worth $420. The position accounts for ﹤0.01% of the portfolio, ranked #5577.

Tower Research Capital (TRC) first reported a position in PMI in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.02K in Q1 2026. 17 funds tracked by Wall St. Rank hold PMI as of Q3 2026.

  • Tower Research Capital (TRC) held 100 shares of Picard Medical worth $420 as of Q3 2026.
  • Tower Research Capital (TRC) sold 138 Picard Medical shares in Q3 2026, an estimated $769.
  • Picard Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5577 holding.
  • Tower Research Capital (TRC) first reported a position in Picard Medical in Q4 2025 and has held it in 4 quarters since.
  • Tower Research Capital (TRC)'s Picard Medical position peaked at $3.02K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Picard Medical as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.